Casey Woodring
Stock Analyst at J.P. Morgan
(4.57)
# 1,100
Out of 5,058 analysts
215
Total ratings
68.2%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTR Avantor | Reiterated: Hold | $12 → $15 | $16.42 | -8.65% | 4 | Oct 16, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $310 → $345 | $300.15 | +14.94% | 23 | Oct 16, 2026 | |
| DHR Danaher | Reiterated: Buy | $220 → $250 | $229.04 | +9.15% | 9 | Oct 16, 2026 | |
| ILMN Illumina | Reiterated: Buy | $230 → $320 | $262.54 | +21.89% | 9 | Oct 16, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $285 → $295 | $266.90 | +10.53% | 3 | Oct 16, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Hold | $1,400 → $1,550 | $1,622.29 | -4.46% | 6 | Oct 16, 2026 | |
| RGEN Repligen | Reiterated: Buy | $175 → $200 | $175.42 | +14.01% | 5 | Oct 16, 2026 | |
| RVTY Revvity | Reiterated: Hold | $110 → $155 | $152.64 | +1.55% | 5 | Oct 16, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $690 → $760 | $690.00 | +10.14% | 7 | Oct 16, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $50 → $70 | $69.86 | +0.20% | 6 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $400 → $435 | $436.95 | -0.45% | 7 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $24.02 | +24.90% | 1 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 | $54.78 | +9.53% | 5 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $35 | $30.56 | +14.53% | 6 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $158.60 | +22.95% | 8 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $460 | $393.44 | +16.92% | 7 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $12 | $12.91 | -7.05% | 21 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $55 | $46.13 | +19.23% | 21 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $17 | $17.89 | -4.97% | 16 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $70 | $64.72 | +8.16% | 6 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $190 | $172.97 | +9.85% | 5 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $35 | $25.28 | +38.45% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $130 | $98.12 | +32.49% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $155 → $165 | $170.18 | -3.04% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.61 | n/a | 5 | Aug 9, 2024 |
Avantor
Oct 16, 2026
Reiterated: Hold
Price Target: $12 → $15
Current: $16.42
Upside: -8.65%
Charles River Laboratories International
Oct 16, 2026
Reiterated: Buy
Price Target: $310 → $345
Current: $300.15
Upside: +14.94%
Danaher
Oct 16, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $229.04
Upside: +9.15%
Illumina
Oct 16, 2026
Reiterated: Buy
Price Target: $230 → $320
Current: $262.54
Upside: +21.89%
IQVIA Holdings
Oct 16, 2026
Reiterated: Buy
Price Target: $285 → $295
Current: $266.90
Upside: +10.53%
Mettler-Toledo International
Oct 16, 2026
Reiterated: Hold
Price Target: $1,400 → $1,550
Current: $1,622.29
Upside: -4.46%
Repligen
Oct 16, 2026
Reiterated: Buy
Price Target: $175 → $200
Current: $175.42
Upside: +14.01%
Revvity
Oct 16, 2026
Reiterated: Hold
Price Target: $110 → $155
Current: $152.64
Upside: +1.55%
Thermo Fisher Scientific
Oct 16, 2026
Reiterated: Buy
Price Target: $690 → $760
Current: $690.00
Upside: +10.14%
10x Genomics
Oct 16, 2026
Reiterated: Hold
Price Target: $50 → $70
Current: $69.86
Upside: +0.20%
Oct 16, 2026
Reiterated: Hold
Price Target: $400 → $435
Current: $436.95
Upside: -0.45%
Oct 14, 2026
Reiterated: Buy
Price Target: $30
Current: $24.02
Upside: +24.90%
Oct 14, 2026
Downgraded: Hold
Price Target: $60
Current: $54.78
Upside: +9.53%
Oct 14, 2026
Reiterated: Buy
Price Target: $25 → $35
Current: $30.56
Upside: +14.53%
Oct 14, 2026
Reiterated: Buy
Price Target: $195
Current: $158.60
Upside: +22.95%
Oct 14, 2026
Reiterated: Buy
Price Target: $360 → $460
Current: $393.44
Upside: +16.92%
Oct 14, 2026
Reiterated: Sell
Price Target: $12
Current: $12.91
Upside: -7.05%
Oct 14, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $46.13
Upside: +19.23%
Oct 14, 2026
Downgraded: Sell
Price Target: $18 → $17
Current: $17.89
Upside: -4.97%
Oct 14, 2026
Reiterated: Hold
Price Target: $45 → $70
Current: $64.72
Upside: +8.16%
Aug 27, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $172.97
Upside: +9.85%
Aug 10, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $25.28
Upside: +38.45%
Aug 6, 2026
Reiterated: Buy
Price Target: $145 → $130
Current: $98.12
Upside: +32.49%
Aug 4, 2026
Reiterated: Hold
Price Target: $155 → $165
Current: $170.18
Upside: -3.04%
Aug 9, 2024
Reiterated: Hold
Price Target: $6 → $5
Current: $3.61
Upside: n/a